🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
BBN
$BBNX
🔒 US EquitiesBeta Bionics, Inc.
AVG HISTORICAL GAP
+2.19%
MAX GAP RECORD
+15.73%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $BBNX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$BBNX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 27, 2026 Earnings Release 2026-10-27 (AFTER CLOSE (21:00)) |
-11.50%
|
| Jul 29, 2026 Earnings Release 2026-07-29 (AFTER CLOSE) |
+5.27%
|
| Apr 21, 2026 Earnings Release 2026-04-21 (AFTER CLOSE) |
+5.62%
|
| Feb 17, 2026 Earnings Release 2026-02-17 (AFTER CLOSE) |
-7.73%
|
| Oct 28, 2025 Earnings Release 2025-10-28 (AFTER CLOSE) |
+15.73%
|
| Jul 29, 2025 Earnings Release 2025-07-29 (AFTER CLOSE) |
+3.00%
|
| May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE) |
+4.93%
|
| Jan 30, 2025 Earnings Release 2025-01-30 (UNDETERMINED) |
+0.00%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
7.7%
Bullish Gaps (5)
Bearish Gaps (2)
Neutral / Flat (0)
📖 Intelligence Summary
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗